Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

1 of 1 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT05694065Active Not Recruiting

Functional ComprEhensive AssessmenT by IVUS Reconstruction in Patients With Suspected IschEmic Heart Disease (FEATURE)

Role: collaborator

NCT04767607Completed

Study of Prediction of Ovarian Reserve in Yong Breast Cancer Patients Treated With Chemotherapy

Role: collaborator

NCT05020301Not ApplicableUnknown

Investigation of Functional Brain Network in Altered Meditation State With Multimodal Neuroimaging

Role: collaborator

All 3 trials loaded